Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study

Authors: Hong Zhu, Jingmin Zhu, Yingyu Zhou, Linghan Shan, Cui Li, Yu Cui, Zheng Kang, Mingli Jiao, Huan Liu, Lijun Gao, Qunhong Wu, Yanhua Hao

Source: Frontiers in Public Health, Vol 10 (2022)

Subject Terms: accessibility, availability, cost, anticancer drugs, National Reimbursement Drug List Negotiation, China, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fpubh.2022.921093/full; https://doaj.org/toc/2296-2565

Access URL: https://doaj.org/article/7853203149994d57b4101be3b3b95d19